Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease is a research paper published in npj Vaccines (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R41 CA203456
NCI NIH HHS
Grant: R42 CA203456
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Grant: R01AI136031
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
Grant: 0000
Division of Cancer Prevention, National Cancer Institute (NCI Division of Cancer Prevention)
Grant: CA203456
National Institutes of Health
Grant: 5R01AI136031-06
Oxidative Response Networks in Chagasic Cardiomyopathy
National Institutes of Health
Grant: 5R42CA203456-03
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
FWCI
1.43
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals